产品详情
中文名称:右旋糖酐40 | 英文名称:Dextran40 |
CAS:9004-54-0 | 有效期: 一年 |
产地: 陕西、西安 | 纯度规格: ≥99% |
2018-07-24
右旋糖酐40
Dextran40
RMB
1000
一年
陕西、西安
≥99%
CAS: 9004-54-0
MF: [C6H10O5]n
EINECS:232-677-5
Grade: injection, EP6.0 standard
Dextranum; Plavoles;in-tradex; Gentran;Polyglucino Mucrose
clinical injection, synthesize dextran gel and other important derivatives; plasma volume expander, improve the microcirculation, keep blood from bolting formation and benefit urine function; Cure to use the film layer
Molecular weight: 35000~45000
Molecular weight : M10 ≤110000
Distribution: M90 ≥7000
Solubility: Very soluble in water, very slightly in alcohol, Clear and colorless solution
Appearance: White powder
Solubility: Very soluble in water and slightly soluble in alcohol.
Package: 25Kg/drum
Benefit: Dextran 40 is primarily used in the medical industries for its abilities to moderate blood viscosity and decrease vascular thrombosis. Other uses include acting as a lubricant in eye drop products and advancing microcirculation within the body.
关键字: Dextran40;API;avtive pharmaceutical ingredients
公司简介
Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements.
There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development.
We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most
成立日期 |
1995-05-26
(30年)
|
注册资本 |
7500.000000万
|
员工人数 |
500人以上 |
年营业额 |
¥ 1亿以上 |
主营行业 |
医药中间体,原料药 |
经营模式 |
工厂 |